Precise Robotically IMplanted Brain-Computer InterfacE
Condition(s) studied
Investigational drug(s) / intervention(s)
N1 Implant: The N1 Implant is a type of implantable brain-computer interface
R1 Robot: The R1 Robot is a robotic electrode thread inserter that implants the N1 Implant.
Study summary
The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
Eligibility
Primary outcome measure(s)
- Device-Related Adverse Events (AE) — 12 months post-implant
- Procedure-Related Adverse Events (AE) — 12 months post-implant
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | Recruiting |
| University of Miami | Miami | Florida | Recruiting |
More Neuralink Corp trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06429735 on ClinicalTrials.gov ↗ ← All trials in the USA